Tcr2 Therapeutics Inc.

STATE STREET CORP

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

137,219

Value ($000)

206

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	206	0.0%	137,219	3/31/2023
2022 Q4	5/15/2023	109	0.0%	109,319	12/31/2022
2022 Q3	11/15/2022	197	0.0%	109,319	9/30/2022
2022 Q2	8/15/2022	317	0.0%	109,319	6/30/2022
2022 Q1	5/16/2022	1,444	0.0%	523,157	3/31/2022
2021 Q4	2/14/2022	2,401	0.0%	515,189	12/31/2021
2021 Q3	11/15/2021	12,890	0.0%	1,514,717	9/30/2021
2021 Q2	8/16/2021	36,614	0.0%	2,231,224	6/30/2021
2021 Q1	7/9/2021	48,319	0.0%	2,188,354	3/31/2021
2020 Q4	2/16/2021	30,220	0.0%	977,060	12/31/2020
2020 Q3	11/10/2020	7,264	0.0%	357,463	9/30/2020
2020 Q2	8/14/2020	3,973	0.0%	258,683	6/30/2020
2020 Q1	6/19/2020	1,572	0.0%	203,155	3/31/2020
2019 Q4	2/6/2020	2,904	0.0%	203,352	12/31/2019